ProPhase Labs, Inc.

PRPH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $3.2M $441.0K $1.7M $2.9M $1.6M $572.0K $5.5M $8.2M
Accounts Receivable $1.9M $5.8M $4.0M $5.8M $5.3M $5.4M $3.2M $4.8M
Inventory $1.5M $2.7M $4.3M $3.3M $2.5M $2.1M $2.7M $1.7M
Total Current Assets $28.4M $9.6M $11.9M $13.5M $11.3M $10.7M $13.2M $15.8M
Property, Plant & Equipment $2.7M $3.2M $3.0M $2.6M $2.6M $2.4M $2.3M $2.4M
Goodwill
Intangible Assets (Excl. Goodwill) $0 $3.6M $3.6M $3.6M $3.6M
Total Assets $33.7M $12.8M $14.8M $16.1M $17.4M $16.7M $19.1M $21.7M
Liabilities
Accounts Payable $562.0K $2.2M $990.0K $667.0K $1.0M $1.3M $885.0K $489.0K
Total Current Liabilities $1.8M $6.8M $4.5M $5.2M $4.6M $4.9M $7.9M $8.2M
Long-Term Debt $1.5M $100.0K
Total Liabilities $1.8M $6.8M $6.0M $5.3M $4.8M $5.2M $7.9M $8.2M
Stockholders' Equity
Retained Earnings $20.9M $-19.7M $-16.8M $-13.2M $-5.4M $-5.8M $-4.7M $-2.0M
Total Stockholders' Equity $31.8M $6.0M $8.8M $10.7M $12.6M $11.5M $11.2M $13.5M
← Newer Page 2 of 3 Older →